127 related articles for article (PubMed ID: 32711345)
1. An NAD
Dong L; Yu L; Li H; Shi L; Luo Z; Zhao H; Liu Z; Yin G; Yan X; Lin Z
iScience; 2020 Aug; 23(8):101351. PubMed ID: 32711345
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma.
Kim Y; Jung KY; Kim YH; Xu P; Kang BE; Jo Y; Pandit N; Kwon J; Gariani K; Gariani J; Lee J; Verbeek J; Nam S; Bae SJ; Ha KT; Yi HS; Shong M; Kim KH; Kim D; Jung HJ; Lee CW; Kim KR; Schoonjans K; Auwerx J; Ryu D
Drug Resist Updat; 2024 Mar; 73():101054. PubMed ID: 38277756
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through Krüpple-like factor 4 deacetylation.
Zhang J; Xu C; Tang X; Sun S; Liu S; Yang L; Chen Y; Yang Q; Wei TW; Wu X; Wang J; Wang C; Yan X; Yang L; Niu Y; Gou D; Shyy JYJ; Liu B
Cardiovasc Res; 2024 Mar; 120(4):403-416. PubMed ID: 38198357
[TBL] [Abstract][Full Text] [Related]
4. USP39 Serves as a Deubiquitinase to Stabilize STAT1 and Sustains Type I IFN-Induced Antiviral Immunity.
Peng Y; Guo J; Sun T; Fu Y; Zheng H; Dong C; Xiong S
J Immunol; 2020 Dec; 205(11):3167-3178. PubMed ID: 33127822
[TBL] [Abstract][Full Text] [Related]
5. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.
Yuan J; Zhang G; Li X; Ma Q; Cheng W; Wang W; Zhang B; Hu T; Song G
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255748
[TBL] [Abstract][Full Text] [Related]
6. SIRT7 Facilitates CENP-A Nucleosome Assembly and Suppresses Intestinal Tumorigenesis.
Liu X; Li C; Li Q; Chang HC; Tang YC
iScience; 2020 Sep; 23(9):101461. PubMed ID: 32861997
[TBL] [Abstract][Full Text] [Related]
7. SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1.
Simonet NG; Thackray JK; Vazquez BN; Ianni A; Espinosa-Alcantud M; Morales-Sanfrutos J; Hurtado-Bagès S; Sabidó E; Buschbeck M; Tischfield J; De La Torre C; Esteller M; Braun T; Olivella M; Serrano L; Vaquero A
Sci Adv; 2020 Jul; 6(30):eaaz2590. PubMed ID: 32832656
[TBL] [Abstract][Full Text] [Related]
8. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma.
Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G
Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698
[TBL] [Abstract][Full Text] [Related]
9. The Roles of the Ubiquitin-Proteasome System in the Endoplasmic Reticulum Stress Pathway.
Qu J; Zou T; Lin Z
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546413
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
12. SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
Ianni A; Kumari P; Tarighi S; Simonet NG; Popescu D; Guenther S; Hölper S; Schmidt A; Smolka C; Yue S; Krüger M; Fiorillo C; Vaquero A; Bober E; Braun T
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495326
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Epidemiologic Characteristics of Children with Hand, Foot and Mouth Disease in China.
Hu H; Ge W; Yan J
Iran J Public Health; 2023 Apr; 52(4):773-779. PubMed ID: 37551194
[TBL] [Abstract][Full Text] [Related]
14. Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma.
Yang J; Li S; He J; Xu Q; Xie M; Yang C; Wang H; Zhang Y; Wan Q; Xiang M
Cell Death Discov; 2023 Apr; 9(1):139. PubMed ID: 37117198
[TBL] [Abstract][Full Text] [Related]
15. 5'-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I.
Wu C; Liu D; Zhang L; Wang J; Ding Y; Sun Z; Wang W
Front Med; 2023 Jun; 17(3):476-492. PubMed ID: 36973570
[TBL] [Abstract][Full Text] [Related]
16. Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC.
Fan L; Xia P; Wang J; Xu S; Qiu Z; Wu Y; Feng M; Zhao Q; Wang H; Li X
Mol Carcinog; 2023 Jun; 62(6):820-832. PubMed ID: 36920046
[TBL] [Abstract][Full Text] [Related]
17. Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation.
Han X; Huang J; Lu J; He F; Wang F; Li S; Zhong H; Yu H; Pu W
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1943-1955. PubMed ID: 36869905
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Hernandezine on the Proliferation of Hepatocellular Carcinoma.
Kuok C; Wang Q; Fong P; Qin Y; Meng L
Biol Pharm Bull; 2023; 46(2):245-256. PubMed ID: 36724952
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of Cell Lines HepG2, Hep3B217 and SNU387 as Models for Porcine Epidemic Diarrhea Coronavirus Infection.
Lv L; Luo H; Yu L; Tong W; Jiang Y; Li G; Tong G; Li Y; Liu C
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560758
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration
Guo Y; Hu HT; Xu SJ; Xia WL; Zhao Y; Zhao XH; Zhu WB; Li FT; Li HL
Front Oncol; 2022; 12():1023801. PubMed ID: 36439456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
